Abstract Fibroblast growth factor-1 (FGF-1) is secreted by astrocytes and stimulates apolipoprotein E (apoE)-HDL biogenesis by an autocrine mechanism to help in recovery from brain injury. In apoE-deficient mouse astrocytes, FGF-1 stimulated cholesterol biosynthesis without enhancing its release, indicating a signaling pathway independent of apoE biosynthesis upregulation. SU5402, an inhibitor of FGF receptor, inhibited FGF-1-induced phosphorylation of MEK, ERK, and Akt, as well as all the apoE-HDL biogenesis-related events in rat astrocytes. LY294002, an inhibitor of phosphatidylinositide 3-OH kinase (PI3K) and of Akt phosphorylation, inhibited apoE-HDL secretion but not cholesterol biosynthesis, whereas U0126, an inhibitor of MEK and of ERK phosphorylation, inhibited cholesterol biosynthesis but not apoE-HDL secretion. Increase of apoE-mRNA by FGF-1 was not influenced by either inhibitor. When rat apoE/pcDNA3. his was transfected to transformed rat astrocyte GA-1 cells that otherwise do not synthesize apoE (GA-1/25), FGF-1 did not influence apoE-mRNA, but did increase the apoE secretion and Akt phosphorylation that were suppressed by LY294002. Lipid biosynthesis was increased by FGF-1 in GA-1/25 cells and suppressed by U0126. FGF-1 upregulates apoE-HDL biogenesis by three independent signaling pathways. The PI3K/Akt pathway upregulates secretion of apoE/apoE-HDL, the MEK/ERK pathway stimulates cholesterol biosynthesis, and an unknown pathway enhances apoE transcription.-Ito, J-i., Y. Nagayasu, K. Okumura-Noji, R. Lu, T. Nishida, Y. Miura, K. Asai, A. Kheirollah, S. Nakaya, and S. Yokoyama. Mechanism for FGF-1 to regulate biogenesis of apoE-HDL in astrocytes. J. Lipid Res. 2007Res. . 48: 2020Res. -2027.
in the CNS could thus account for 25-30% of total body cholesterol in humans (1, 2) . Cholesterol plays many key roles in the CNS, including roles in neurite outgrowth (3, 4) and synapse formation (5) .
Cholesterol homeostasis in animals is maintained by intra-and extracellular regulation of its metabolism (6) , and extracellular transport of cholesterol in vertebrates is carried by the plasma lipoprotein system. However, the blood-brain barrier prevents the CNS from accessing this system, so the CNS operates as a unique and independent CNS-specific lipoprotein system for extracellular cholesterol transport. HDL is a lipoprotein found exclusively in cerebrospinal fluid that contains mainly apolipoprotein E (apoE) and apoA-I (7). Although apoA-I is not synthesized by neural cells, and its origin is uncertain (8, 9) , apoE is known to be synthesized, at least in astrocytes and microglias, to generate apoE-HDL (10, 11) . Many reports suggest that apoE-HDL is a key lipoprotein in the delivery of cholesterol to the neural cells, and this lipoprotein seems to increase in the lesions of injury of brain and nerves (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) .
We reported that astrocytes produce cholesterol-rich HDL with endogenously synthesized apoE and cellular lipid, and that they generate cholesterol-poor HDL with exogenous apoA-I (22) . Astrocytes synthesize and release fibroblast growth factor-1 (FGF-1), and it stimulates the cells in an autocrine manner to produce apoE-HDL when the cells are cultured for longer times, such as 1 month primary and 1 week secondary culture (23, 24) . FGF-1 is produced prior to apoE production in the astrocytes in the peri-injury regions after cryo-injury of mouse brain, and healing of the injury was much delayed in the apoEdeficient mice, although FGF-1 appeared at the same post-injury time (25) . On the basis of these findings, we propose that FGF-1 is a key factor in triggering the recovery process in brain injury by stimulating production of apoE-HDL by an autocrine/paracrine mechanism.
FGF-1 enhances transcription of apoE, cholesterol biosynthesis, and secretion of apoE and cholesterol in its stimulation of apoE-HDL biogenesis in astrocytes. We investigated the mechanism through which FGF-1 stimulates each component reaction for apoE-HDL biogenesis by focusing on intracellular signal transduction pathways in astrocytes. FGF-1 was shown to initiate differential signal transductions for stimulation of cholesterol biosynthesis, apoE transcription, and a posttranscriptional stage for apoE secretion.
MATERIALS AND METHODS

Reagents
LY294002, an inhibitor of phosphatidylinositide 3-OH kinase (PI3K) and U0126, an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), were purchased from Calbiochem. Inhibitors of FGF receptor (SU5402, SU4984), vascular endothelial growth factor receptor (SU5614), epidermal growth factor receptor (AG490), and platelet-derived growth factor receptor (AG17) (26) (27) (28) (29) were also obtained from Calbiochem.
Cell culture
Astrocytes were prepared from 17 day fetal brain of Wistar rats, C57BL/6 wild-type mice, and apoE-deficient C57BL/6 mice according to the method previously described (30) . After the brain was cut into small pieces and treated with 0.1% trypsin solution in Dulbecco's phosphate-buffered saline (DPBS) containing 0.15% glucose (0.1% trypsin/DPBS/G) for 3 min at room temperature, the cell pellet by centrifugation at 1,000 rpm for 3 min was cultured in F-10 medium containing 10% fetal calf serum (10% FCS/F-10) for rat astrocytes or 10% FCS/DMEM for mouse astrocytes at 37jC for 1 week as primary culture. After treatment with 0.1% trypsin/DPBS/G containing 1 mM EDTA, the cells were transferred to a fresh plate and cultured in 10% FCS/F-10 or 10% FCS/DMEM for 1 week as secondary culture. Transformed rat astrocyte cell line GA-1 cells (31) were cultured in 10% FCS/F-10.
Construction of expression vectors for apoE and its transfection
Total RNA was extracted from rat astrocyte primary cultures, and the first-strand cDNA was prepared by SuperScript II reverse transcriptase and random hexamer primers (Gibco BRL). The apoE cDNA of rat astrocytes was amplified by PCR with the primers: sense, 5 ¶-TGGGAAGATGAAGGCTCTGT-3 ¶, and antisense, 5 ¶-GGCGTAGGTGAGGGATGAT-3 ¶ designed from the sequence of rat apoE mRNA (32), J700705, residues at 17-36 for sense and at 959-977 for antisense primer, by using pfu DNA polymerase and Taq polymerase. The products were cloned into pGEM-T Easy vector (Promega). We confirmed the insert DNA encoding APE_RAT (apoE precursor) by GenBank database analysis. After digestion by EcoRI (Takara) and electrophoresis in 1% agarose gel, the insert DNA was extracted and cloned into mammalian expression vector pcDNA3.1His (Invitrogen). The expression vector and control mock vector were transfected to GA-1 cells, transformed rat astrocytes that produce no apoE, FGF-1 regulation of biogenesis of apoE-HDL in astrocytesby using the low-toxicity polyamine transfection reagent, TransIT-LT (Mirus Corp.). Transfected cells were selected by culturing in 10% FCS/F-10 containing 800 mg/ml aminoglycoside antibiotics, G-418. The most highly apoE-positive clone was selected as the GA-1/25 cell. Mock vector (pcDNA3.1His)-transfected GA-1 cells were used as control GA-1 cells, and lack of apoE expression was confirmed for the mRNA and protein.
Preparation of cytosol and membrane fractions
Cytosol and membrane fractions of rat astrocytes and GA-1/ 25 cells were prepared according to the method previously described (33) . Briefly, cell pellet was obtained by centrifugation at 1,000 rpm for 10 min after washing with DPBS four times and harvesting with a rubber policeman. The cell pellet was treated with cold hypotonic buffer, 0.02 M Tris-HCl, pH 7.5, containing a protease inhibitor cocktail (Sigma), for 15 min with strong Vortex mixing 25 times for 10 s every 5 min. The cell suspension was centrifuged at 5,000 rpm (1,000 g) for 20 min for preparation of denuclear supernatant fraction, and it was further centrifuged at 90 krpm (367,000 g) for 30 min at 4jC in a Hitachi S100AT6 rotor to obtain the cytosol as a supernatant and the membrane fraction as a pellet (34) .
Analysis of proteins by Western blotting
The conditioned medium was treated with 10% TCA and centrifuged at 15,000 rpm for 20 min to obtain protein pellet after removal of cell debris by centrifugation at 15,000 rpm for 30 min. Proteins in the cell or in the conditioned medium were separated in 0.5% sodium dodecylsulfate/12% polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a Sequi-BlotTM PDVF membrane (Bio Rad). The membrane was immunostained with specific antibodies for proteins to be analyzed: rabbit antibodies against MEK1/2 and phospho-MEK 1/2 (Ser 217/221, P-MEK) (Cell Signaling); rabbit antibodies against p44/42 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK), and phospho-p44/42 MAPK (Thr202/Tyr204, P-ERK) (Cell Signaling); mouse antibody against PKBa (Akt) (BD Transduction); rabbit antibody against phosphoAkt (Thr308, P-Akt) (Cell Signaling); rabbit antibody against Raf-1 (BioVision); mouse antibody against phospho-Raf-1 (ser338) (Upstate); and rabbit antibody against rat apoE (a generous gift from Dr. Jean Vance, University of Alberta). Immunoreactive bands were visualized as previously described and semiquantified by digital scanning using Adobe Photoshop software (23) . Data demonstrated represent a typical set out of several experiments repeated in each series.
RT-PCR
Total cellular RNA was extracted from rat astrocytes and GA-1/25 cells with ISOGEN (Wako Life Science), and reverse transcribed to cDNA using a Super Script Preamplification System (Gibco BRL). The resulting cDNA was subjected to PCR by using the DNA primers for rat apoE-mRNA, as described in a previous paper (23) . After the electrophoresis of the products, agarose gel was stained with freshly prepared SYBR Gold nucleic acid gel stain solution. Bands were detected by using an ultraviolet transilluminator (UVP NLM-20E) at 302 nm. The apoE primer pairs were 5 ¶-AAGCCCGTCGGTGTCCATGG as sense and 5 ¶-GATGG-CACAGTGGATGGGAC as antisense, and the ABCA1 primer pairs were 5 ¶-CATCGGCATCAATGGTAGTG -3 ¶ and 5 ¶-CCCAAGAGA-GTGGAGAGACG -3 ¶ (24).
Biosyntheses and secretion of cholesterol and phospholipid
Procedures for analysis of cellular lipid metabolism were described in our previous publication (24) . After washing with DPBS four times, rat astrocytes or rat GA-1/25 cells at the con- H]acetate (20 mCi/ml) for 2 h (F). Radioactivity of mevalonolactone was determined after lipid extraction from the cell suspension and separation by TLC. Data represent the average and standard error of the triplicate samples. Significance of change from the non-FGF-1 control is indicated by * as P , 0.05 and ** as P , 0.01. fluent cell density were incubated for 24 h in 0.1% BSA/F-10, or mouse astrocytes in 0.1% BSA/DMEM. To measure secretion of cholesterol and phospholipid, the cells were incubated with 
RESULTS
FGF-1 enhanced release of cholesterol and cholinephospholipid from mouse astrocytes, whereas it failed to increase the lipid release from apoE-deficient mouse astrocytes (Fig. 1) . In contrast, FGF-1 enhanced cholesterol biosynthesis as well as phospholipid biosynthesis from acetate, in both wild-type and apoE-deficient mouse astrocytes (Fig. 2) . Cholesterol biosynthesis was enhanced at the steps both prior to and after mevalonic acid biosynthesis (Fig. 2) . The results suggest that upregulation of lipid biosynthesis is independent of apoE-HDL biogenesis but that the increase of lipid release by FGF-1 is dependent on production of apoE.
Signaling pathways by FGF-1 stimulation were investigated by using rat astrocytes. Figure 3A demonstrates phosphorylation of the signal proteins MEK, ERK, and Akt by incubation of the cells with FGF-1. Figure 3B shows that Fig. 3 . Intracellular signal production induced by FGF-1 in rat astrocytes. A: Phosphorylation of signal proteins by FGF-1. Rat astrocytes were stimulated with 50 ng/ml of FGF-1 in 0.02% BSA/F-10 for the indicated time. The cytosol fraction and membrane fraction were prepared from the cells as described in Materials and Methods. After precipitation with 10% TCA, the protein of both fractions (70 mg each) was analyzed by immunoblotting for MEK, phospho (Pi)-MEK, ERK, Pi-ERK, Akt, and Pi-Akt by using their respective specific antibodies. B: Inhibition of the FGF-1-induced reactions by the FGF receptor inhibitors. The cells were stimulated with FGF-1 for 5 min as above after pretreatment with the inhibitors of FGF-1 receptor (SU5402, SU4984), vascular endothelial growth factor (SU5614), epidermal growth factor (AG490), and platelet-derived growth factor (AG17) (10 mM, respectively) for 1 h. The whole cells (100 mg proteins/lane) were applied on SDS-PAGE and analyzed by Western blotting for MEK, Pi-MEK, ERK, Pi-ERK, Akt, and Pi-Akt. C, D: Inhibition of phosphorylation of signal proteins by specific signal inhibitors. Rat astrocytes were pretreated with 10 mM LY294002, a phosphatidylinositide 3-OH kinase (PI3K) inhibitor, or 10 mM U0126, an MEK inhibitor, for 1 h in 0.1% BSA/F-10, followed by incubation with FGF-1 (0 or 50 ng/ml) for 5 min. After washing with DPBS, the cytosol fraction (70 mg protein) was prepared and analyzed by immunoblotting for Akt, Pi-Akt, ERK, Pi-ERK, MEK, and Pi-MEK. Numbers indicate relative phosphorylation of each protein in arbitrary units based on digital scanning of bands.
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phosphorylation of all these proteins was inhibited by the inhibitors of the FGF receptors (SU5402 and SU4984) but not by those of other receptors (SU5614, AG490, and AG17), showing that these reactions are mediated by FGF-1 and its receptors. Akt phosphorylation by FGF-1 was selectively inhibited by a PI3K inhibitor, LY294002, and phosphorylation of MEK and ERK was inhibited by an MEK inhibitor, U0126 (Fig. 3C, D) . The receptor inhibitor SU5402 inhibited the FGF-1-induced reactions for apoE-HDL biogenesis, such as increase of cholesterol release and induction of cholesterol biogenesis (Fig. 4) , showing that these reactions are all dependent on the FGF-1 receptors. Cells could not tolerate long-term exposure to the receptor inhibitor, so apoE secretion was unable to be examined because it requires long-term incubation.
A PI3K inhibitor, LY294002, but not the MEK inhibitor, U0126, inhibited the increase by FGF-1 of apoE secretion from astrocytes, as 1.0 and 2.9 times increase, respectively, in comparison to 5.6 times increase in control, based on quantification of immunoreactive bands (24) . Being consistent with this result, increase of cellular cholesterol release by FGF-1 was inhibited by LY294002 but not by U0126 (Fig. 5A) . In contrast, stimulation of cholesterol biosynthesis by FGF-1 was canceled by U0126 but not by LY294002 (Fig. 5B) .
The effects of FGF-1 on apoE expression and its secretion were further examined in detail. Rat apoE was transfected with a vector promoter in the form of apoE/ pcDNA3.his into rat astrocyte cell line GA-1 cells that otherwise do not produce apoE (GA-1/25). The effect of FGF-1 on this cell was examined for apoE biosynthesis and secretion. Figure 6A demonstrates phosphorylation of Akt, MEK, and ERK by FGF-1 and inhibition of Akt phosphorylation by LY294002, showing that FGF-1 receptor and subsequent signaling pathways normally function in this cell line. Figure 6B shows that FGF-1 increases apoE mRNA in rat astrocytes, as well as TO901317, an agonist of LXR. In contrast, neither of these compounds influenced the apoE mRNA level in GA-1/25 cells as expected. The increase of mRNA by FGF-1 in astrocytes was not influenced by LY294002 or U0126, indicating that signaling to upregulate apoE transcription is independent of either the P13K/Akt or the MEK/ERK pathway (Fig. 6C) . Interestingly, apoE secretion was increased by FGF-1 and reversed by LY29002, despite of the lack of effect of FGF-1 and LY29004 on the apoE transcription step (Fig. 6D) . Because the change of apoE level in the medium and cell is reciprocal, the effect of FGF-1 seems to be on the apoE transport/secretion rather than its translation. Consistent 14 C]acetate (4 mCi/ml) for 16 h in the presence or absence of FGF-1 (50 ng/ml) and SU5402 (5 mM) in 0.1% BSA/DMEM after washing with DPBS three times and replacement with 0.1% BSA/DMEM. After washing with DPBS, the cells were further incubated for 6 h in 0.02% BSA/F-10. Lipid was extracted from the conditioned medium and separated by TLC to determine radioactivity in cholesterol. B: Cholesterol biosynthesis. The cells were stimulated with FGF-1 (0 or 50 ng/ml) for 24 h in the presence or absence of SU5402 (5 mM). After washing with DPBS, the cells were incubated with [ 14 C]acetate (4 mCi/ml) in fresh 0.02% BSA/F-10 for 2 h. Lipid was extracted from the cells and separated by TLC to determine radioactivity in cholesterol. Data represent the average and standard error of the triplicate samples. Significance of change by FGF-1 is indicated by * as P , 0.05 and ** as P , 0.01. with these results, both the FGF-1 receptor inhibitor and the P13K inhibitor inhibited the increase of cellular cholesterol release by FGF-1 in GA-1/25 cells (Fig. 6E, F) . It was also shown in GA-1/25 cells that inhibition of an MEK/ERK pathway resulted in suppression of the FGF-1-induced lipid biosynthesis (Fig. 7) , again showing differential signal transduction for the apoE/HDL release by a P13K/Akt pathway and lipid biosynthesis by an MEK/ ERK pathway. DISCUSSION FGF-1 is a stimulant for proliferation and cell differentiation of mesodermal and neuroectodermal cells such as fibroblasts and astrocytes (35) . Most studies of this factor have focused on its activity in promoting cell growth and differentiation. We recently reported that FGF-1 is produced by long-cultured rat astrocytes and stimulates syntheses and secretion of apoE-HDL, perhaps by an autocrine mechanism (24) . We here characterized the FGF-1 function to stimulate the apoE-HDL secretion in astrocytes with respect to differential signal transduction pathways for various component reactions of apoE-HDL biogenesis.
The results are summarized as follows: 1) FGF-1 enhances the reactions for apoE-HDL biogenesis via the FGF-1 receptors; 2) FGF-1 stimulates cholesterol biosynthesis independent of apoE production; 3) a PI3K inhibitor, LY294002, inhibited the FGF-1-stimulated release of cholesterol and apoE without influencing apoE mRNA expression, and an MEK inhibitor, U0126, inhibited cholesterol biosynthesis stimulated by FGF-1. Thus, we conclude that FGF-1 upregulates apoE-HDL biogenesis by using at least three independent signaling pathways, a P13K/Akt pathway for transport/ secretion of apoE, an MEK/ERK pathway for cholesterol and lipid biosynthesis, and perhaps an independent pathway for apoE transcription. All of these pathways are probably initiated by the interaction of FGF-1 with its receptors. The pathway to stimulate transcription of the apoE gene is being investigated in detail by using reporter genes.
The FGF-1-initiated pathways should be important reactions for astrocytes to generate apoE-HDL in response to brain injury for recovery. This hypothesis is supported by our own findings that the healing of cryo-injury is substantially delayed in the apoE-deficient mouse brain, and production of FGF-1 in astrocytes in the peri-injury area was detected prior to the production of apoE in these cells (25) . FGF-1 production was shown in the apoE-deficient FGF-1 regulation of biogenesis of apoE-HDL in astrocytesastrocytes at the same timing as the wild-type mouse brain after the brain injury (25) . There is also a report that the FGF-1-induced signal to activate protein kinase B/Akt contributes to neuroprotection by acting against glutamate toxicity through suppression of glycogen synthase kinase-3b activity (36) .
Independent regulation of cholesterol and lipid biosynthesis by FGF-1 through an MEK/ERK pathway may be related to a more general function of FGF-1. FGF-1 stimulates the cell division of astrocytes, and ERK/MAP kinase regulates the cell cycle of astrocytes (37) . Therefore, the increase by FGF-1 of cholesterol biosynthesis may be more directly related to cell proliferation.
Identification of the trigger for astrocytes to produce and release FGF-1 is under investigation, especially in relation to brain injury. The FGF-1-transfected cells release FGF-1 under heat shock conditions (38) . Thus, astrocytes may cause the increase of production and release of FGF-1 under a certain stress. The cellular environment in longterm culture in vitro may be one of these conditions. Brain injury could cause various types of stress around the lesions, such as hypoxia, oxidative stress, or other conditions that may trigger production of FGF-1 in astrocytes. It is important to identify specific stress conditions under which astrocytes will react in such a manner to establish the pathophysiological relevance of these reactions. Understanding the details of the mechanism for triggering apoE-HDL biogenesis in brain damage will lead to the development of technology to assist the healing process in brain injury, either acute or chronic, such as cerebral infarction and Alzheimer's disease. 
